Yue‐Zhong Shu
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Microbial Natural Products and Biosynthesis, Pharmacogenetics and Drug Metabolism, HIV/AIDS drug development and treatment, Analytical Chemistry and Chromatography
Most-Cited Works
- → Metabolic and Pharmaceutical Aspects of Fluorinated Compounds(2020)643 cited
- → Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective(1998)513 cited
- → Stephacidin A and B: Two Structurally Novel, Selective Inhibitors of the Testosterone-Dependent Prostate LNCaP Cells(2002)222 cited
- → Discovering Drugs through Biological Transformation: Role of Pharmacologically Active Metabolites in Drug Discovery(2004)148 cited
- → Metabolism of paeoniflorin and related compounds by human intestinal bacteria.(1985)83 cited
- → Role of Biotransformation Studies in Minimizing Metabolism-Related Liabilities in Drug Discovery(2008)78 cited
- → Studies on dental caries prevention by traditional medicines. X Antibacterial action of phenolic components from mace against Streptococcus mutans.(1986)69 cited
- → A Strategy to Minimize Reactive Metabolite Formation: Discovery of (S)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist(2009)54 cited
- → A triterpene from the fruits of Rubus chingii(1988)53 cited
- → Metabolism of Swertiamarin fromSwertia japonicaby Human Intestinal Bacteria(1989)52 cited